4//SEC Filing
Atlas Venture Fund XII, L.P. 4
Accession 0001209191-22-042614
CIK 0001798749other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:28 PM ET
Size
5.3 KB
Accession
0001209191-22-042614
Insider Transaction Report
Form 4
Atlas Venture Fund XII, L.P.
10% Owner
Transactions
- Other
Common Stock
2022-07-15−310,388→ 2,327,909 total
Footnotes (1)
- [F1]Represents a pro rata distribution, and not a purchase or sale of securities, by Atlas Venture Fund XII, L.P. ("Atlas Venture Fund XII") to its general partner and limited partners without additional consideration. This distribution was effected pursuant to a plan adopted by Atlas Venture Fund XII pursuant to Rule 10b5-1 on November 24, 2021.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001812049
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 5:28 PM ET
- Size
- 5.3 KB